Inflammation as a central mechanism in Alzheimer's disease

Kinney, Jefferson W., Bemiller, Shane M., Murtishaw, Andrew S., Leisgang, Amanda M., Salazar, Arnold M., Lamb, Bruce T.·2018·Alzheimer's & Dementia: Translational Research & Clinical Interventions
DOI 10.1016/j.trci.2018.06.014

Cited by (1,008)

Items 101–200 of 1,008

  1. Retinal biomarkers for Alzheimer’s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis
    Cecília Nóra Czakó, Tibor Kovács, Zoltan I. Ungvari, Anna Csiszár, Andriy Yabluchanskiy, Shannon M. Conley, Tamás Csípő, Ágnes Lipécz, Hajnalka Horváth, Gábor László Sándor et al. · 2020 · GeroScience
  2. APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-κB activation
    Laurie Arnaud, Philippe Benech, Louise Greetham, Delphine Stephan, Angélique Jimenez, Nicolas Jullien, Laura García‐González, Philipp O. Tsvetkov, François Devred, Ignacio Sancho-Martinez et al. · 2022 · Cell Reports
  3. Electroacupuncture Improves M2 Microglia Polarization and Glia Anti-inflammation of Hippocampus in Alzheimer’s Disease
    Lushuang Xie, Yi Liu, Ning Zhang, Chenyu Li, Aaron F. Sandhu, George E Williams, Yan Shen, Hongying Li, Qiao-Feng Wu, Shu-Guang Yu · 2021 · Frontiers in Neuroscience
  4. Systemic inflammation linking chronic periodontitis to cognitive decline
    Rachel Pei‐Hsuan Wang, Janice Yuen Shan Ho, Wai Keung Leung, Tetsuya Goto, Raymond Chuen‐Chung Chang · 2019 · Brain Behavior and Immunity
  5. Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
    Daniela Liccardo, Federica Marzano, Federica Carraturo, Marco Guida, Grazia Daniela Femminella, Leonardo Bencivenga, Jacopo Agrimi, Armida Addonizio, Imma Melino, Alessandra Valletta et al. · 2020 · Frontiers in Physiology
  6. Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
    Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney · 2023 · Drugs
  7. Implications of Glycosylation in Alzheimer’s Disease
    Haukedal, Henriette, Freude, Kristine K. · 2021 · Frontiers in Neuroscience
  8. Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease
    Yunzhe Zhou, Yan Wang, Meina Quan, Huiying Zhao, Jianping Jia · 2021 · Journal of Alzheimer s Disease
  9. Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
    Sinyor, Benjamin, Mineo, Jocelyn, Ochner, Christopher · 2020 · Journal of Alzheimer s Disease Reports
  10. The role of innate immunity in Alzheimer's disease
    Hannah E. Ennerfelt, John R. Lukens · 2020 · Immunological Reviews
  11. In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic- co -glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer’s Disease
    Li Zhang, Shili Yang, Ling Rong Wong, Hui Xie, Paul C. Ho · 2020 · Molecular Pharmaceutics
  12. Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies
    Gaikwad, Sagar, Senapati, Sudipta, Haque, Md. Anzarul, Kayed, Rakez · 2024 · Alzheimer's & Dementia
  13. Associations between Pro- and Anti-Inflammatory Gastro-Intestinal Microbiota, Diet, and Cognitive Functioning in Dutch Healthy Older Adults: The NU-AGE Study
    van Soest, Annick P. M., Hermes, Gerben D. A., Berendsen, Agnes A. M., van de Rest, Ondine, Zoetendal, Erwin G., Fuentes, Susana, Santoro, Aurelia, Franceschi, Claudio, de Groot, Lisette C. P. G. M., de Vos, Willem M. · 2020 · Nutrients
  14. Exploring ER stress response in cellular aging and neuroinflammation in Alzheimer's disease
    Md. Sahab Uddin, Wing Shan Yu, Lee Wei Lim · 2021 · Ageing Research Reviews
  15. Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults
    Claire André, Stéphane Rehel, Elizabeth Kuhn, Brigitte Landeau, Inès Moulinet, Edelweiss Touron, Valentin Ourry, Gwendoline Le Du, Florence Mézenge, Clémence Tomadesso et al. · 2020 · JAMA Neurology
  16. Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
    Paras Mani Giri, Anurag Banerjee, Arpita Ghosal, Buddhadev Layek · 2024 · International Journal of Molecular Sciences
  17. MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
    Yao-Bo Li, Qiang Fu, Mei Guo, Yang Du, Yuewen Chen, Yong Cheng · 2024 · Translational Psychiatry
  18. Docosahexaenoic acid, 22:6n‐3: Its roles in the structure and function of the brain
    Rahul Mallick, Sanjay Basak, Asim K. Duttaroy · 2019 · International Journal of Developmental Neuroscience
  19. A comprehensive review on the applications of nano-biosensor-based approaches for non-communicable and communicable disease detection
    Rout George Kerry, Kingsley Eghonghon Ukhurebor, Swati Kumari, Ganesh Kumar Maurya, Sushmita Patra, Bijayananda Panigrahi, Sanatan Majhi, Jyoti Ranjan Rout, María del Pilar Rodríguez-Torres, Gitishree Das et al. · 2021 · Biomaterials Science
  20. The neuroprotective potential of carotenoids in vitro and in vivo
    Janani Manochkumar, C. George Priya Doss, Hesham Rushdey El-Seedi, Thomas Efferth, Siva Ramamoorthy · 2021 · Phytomedicine
  21. Systemic inflammatory regulators and risk of Alzheimer’s disease: a bidirectional Mendelian-randomization study
    Chris Ho Ching Yeung, Catherine Mary Schooling · 2020 · International Journal of Epidemiology
  22. New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
    Eveljn Scarian, Camilla Viola, Francesca Dragoni, Rosalinda Di Gerlando, Bartolo Rizzo, Luca Diamanti, Stella Gagliardi, Matteo Bordoni, Orietta Pansarasa · 2024 · International Journal of Molecular Sciences
  23. Lactate metabolism in neurodegenerative diseases
    Chaoguang Yang, Rui‐Yuan Pan, Fangxia Guan, Zengqiang Yuan · 2023 · Neural Regeneration Research
  24. Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
    Weilin Liu, Huawei Lin, Xiaojun He, Lewen Chen, Yaling Dai, Weiwei Jia, Xiehua Xue, Jing Tao, Lidian Chen · 2020 · Translational Psychiatry
  25. Cannabidiol for neurodegenerative disorders: A comprehensive review
    Sukanya Bhunia, Nagesh Kolishetti, Adriana Yndart, Arti Vashist, Madhavan G. Nair · 2022 · Frontiers in Pharmacology
  26. Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury
    Zhiping Mi, Steven H. Graham · 2023 · Ageing Research Reviews
  27. The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle
    Yu Cai, Yangqiqi Zhang, Shuo Leng, Yuanyuan Ma, Quan Jiang, Qiuting Wen, Shenghong Ju, Jiani Hu · 2024 · Neurobiology of Disease
  28. 5-Hydroxymethylfurfural Mitigates Lipopolysaccharide-Stimulated Inflammation via Suppression of MAPK, NF-κB and mTOR Activation in RAW 264.7 Cells
    Fanhui Kong, Bae Hoon Lee, Kun Wei · 2019 · Molecules
  29. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
    Zdeněk Fišar · 2022 · Biomolecules
  30. Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective
    De Simone, Angela, Tumiatti, Vincenzo, Andrisano, Vincenza, Milelli, Andrea · 2021 · Journal of Medicinal Chemistry
  31. Role of Microglial Cells in Alzheimer’s Disease Tau Propagation
    Ena Španić, Lea Langer Horvat, Patrick R. Hof, Goran Šimić · 2019 · Frontiers in Aging Neuroscience
  32. Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model
    Partow Mirzaee Saffari, Sakineh Alijanpour, Nasrin Takzaree, Mousa Sahebgharani, Shahroo Etemad‐Moghadam, Farshid Noorbakhsh, Alireza Partoazar · 2020 · Life Sciences
  33. Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
    Olivia Sheppard, Michael P. Coleman · 2020 · Exon Publications eBooks
  34. Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and microglial activation in an AD model
    Wensheng Wang, Yu Wang, Yu Wang, Guangjing Xie, Shangzhi Liu, Zefei Li, Ping Wang, Junfeng Liu, Lin Li · 2024 · Phytomedicine
  35. Effects of neural stem cell transplantation in Alzheimer’s disease models
    Yoshihito Hayashi, Huan-Ting Lin, Cheng-Che Lee, Kuen‐Jer Tsai · 2020 · Journal of Biomedical Science
  36. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
    Pradeep K. Shukla, David F. Delotterie, Jianfeng Xiao, Joseph F. Pierre, Radhakrishna Rao, Michael P. McDonald, Mohammad Moshahid Khan · 2021 · Cells
  37. Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
    Masaru Tanaka, Zsuzsanna Bohár, László Vécsei · 2020 · Molecules
  38. Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
    Anna Andrea Lauer, Heike Sabine Grimm, Birgit Apel, Nataliya Golobrodska, Lara Kruse, Elina Ratanski, Noemi Schulten, Laura Schwarze, Thomas Slawik, Saskia Sperlich et al. · 2022 · Biomolecules
  39. The Role of Selected Bioactive Compounds in the Prevention of Alzheimer’s Disease
    Wojciech Grodzicki, Katarzyna Dziendzikowska · 2020 · Antioxidants
  40. An overview of the relationship between inflammation and cognitive function in humans, molecular pathways and the impact of nutraceuticals
    Chusana Mekhora, Daniel Joseph Lamport, Jeremy P.E. Spencer · 2024 · Neurochemistry International
  41. Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
    F. Novellino, Valeria Sacca, A. Donato, P. Zaffino, M. Spadea, M. Vismara, B. Arcidiacono, N. Malara, I. Presta, G. Donato · 2020 · International Journal of Molecular Sciences
  42. Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia
    Fionnuala Jordan, Terry J Quinn, Bernadette McGuinness, Peter Passmore, John P Kelly, Catrin Tudur Smith, Kathy Murphy, Declan Devane · 2020 · Cochrane Database of Systematic Reviews
  43. BACE1: More than just a β‐secretase
    Hannah A. Taylor, Lena Przemyłska, Eva M. Clavane, Paul J. Meakin · 2022 · Obesity Reviews
  44. Extracellular vesicles derived from Porphyromonas gingivalis induce trigeminal nerve-mediated cognitive impairment
    Xiaoyang Ma, Yoon-Jung Shin, Jong-Wook Yoo, Hee-Seo Park, Dong‐Hyun Kim · 2023 · Journal of Advanced Research
  45. Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases
    Ju‐Yeun Lee, Jun Pyo Kim, Hyemin Jang, Jaeho Kim, Sung Hoon Kang, Ji Sun Kim, Jong Min Lee, Young Hee Jung, Duk Lyul Na, Sang Won Seo et al. · 2020 · Alzheimer s Research & Therapy
  46. Biomaterials in Neurodegenerative Disorders: A Promising Therapeutic Approach
    Matteo Bordoni, Eveljn Scarian, Federica Rey, Stella Gagliardi, Stephana Carelli, Orietta Pansarasa, Cristina Cereda · 2020 · International Journal of Molecular Sciences
  47. LPS induces microglial activation and GABAergic synaptic deficits in the hippocampus accompanied by prolonged cognitive impairment
    Hyeji Jung, Dongsu Lee, Heejung You, Myung-Ha Lee, Hyeonho Kim, Eunji Cheong, Ji Won Um · 2023 · Scientific Reports
  48. Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions
    Miculas, Denisa Claudia, Negru, Paul Andrei, Bungau, Simona Gabriela, Behl, Tapan, Hassan, Syed Shams ul, Tit, Delia Mirela · 2022 · Cells
  49. P‐glycoprotein: a role in the export of amyloid‐β in Alzheimer's disease?
    Amanda B. Chai, Gavin K. F. Leung, Richard Callaghan, Ingrid C. Gelissen · 2019 · FEBS Journal
  50. MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease
    Naeem, Abdul, Prakash, Ravi, Kumari, Neha, Ali Khan, Mohsin, Quaiyoom Khan, Abdul, Uddin, Shahab, Verma, Sandeep, AB Robertson, Avril, Boltze, Johannes, Shadab Raza, Syed · 2024 · Brain, Behavior, and Immunity
  51. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
    Terzioglu, Gizem, Young-Pearse, Tracy L. · 2023 · Molecular Neurodegeneration
  52. Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease
    Gianluca Antonio Franco, Livia Interdonato, Marika Cordaro, Salvatore Cuzzocrea, Rosanna Di Paola · 2023 · International Journal of Molecular Sciences
  53. Common and Distinct Features of Adult Neurogenesis and Regeneration in the Telencephalon of Zebrafish and Mammals
    N. Diotel, Luisa Lübke, U. Strähle, S. Rastegar · 2020 · Frontiers in Neuroscience
  54. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases
    Marcela Konjevod, Matea Nikolac Perković, Jorge Sáiz, Dubravka Švob Štrac, Coral Barbas, David Rojo · 2020 · Journal of Pharmaceutical and Biomedical Analysis
  55. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19
    Mirren Charnley, Saba Islam, Guneet K. Bindra, Jeremy Engwirda, Julian Ratcliffe, Jiangtao Zhou, Raffaele Mezzenga, Mark D. Hulett, Kyunghoon Han, Joshua T. Berryman et al. · 2022 · Nature Communications
  56. Blood–brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy
    Kozberg, Mariel G, Yi, Irvin, Freeze, Whitney M, Auger, Corinne A, Scherlek, Ashley A, Greenberg, Steven M, van Veluw, Susanne J · 2022 · Brain Communications
  57. Role of pro-inflammatory cytokines in Alzheimer’s disease and neuroprotective effects of pegylated self-assembled nanoscaffolds
    Rani, Varsha, Verma, Rinki, Kumar, Krishan, Chawla, Ruchi · 2023 · Current Research in Pharmacology and Drug Discovery
  58. The role of prebiotics in cognition, anxiety, and depression
    Igor Henrique Rodrigues de Paiva, Eduardo Pereira Duarte-Silva, Christina Alves Peixoto · 2020 · European Neuropsychopharmacology
  59. Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer’s disease after 2 years of survival
    Lidija Radenović, Marija Nenadić, Marzena Ułamek-Kozioł, Sławomir Januszewski, Stanisław Jerzy Czuczwar, Pavle R. Anđjus, Ryszard M. Pluta · 2020 · Aging
  60. The Role of Neurovascular System in Neurodegenerative Diseases
    Ajmal Ahmad, Vanisha Patel, Jianfeng Xiao, Mohammad Moshahid Khan · 2020 · Molecular Neurobiology
  61. The Microbiota-Gut-Brain Axis in Health and Disease and Its Implications for Translational Research
    Melanie Schächtle, Stephan P. Rosshart · 2021 · Frontiers in Cellular Neuroscience
  62. Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia
    Oh. Yoen Kim, Juhyun Song · 2023 · Life Sciences
  63. Long-term exercise pre-training attenuates Alzheimer’s disease–related pathology in a transgenic rat model of Alzheimer’s disease
    Luodan Yang, Chongyun Wu, Yong Li, Yan Dong, Celeste Yin‐Chieh Wu, Reggie Hui‐Chao Lee, Darrell W. Brann, Hung Wen Lin, Quanguang Zhang · 2022 · GeroScience
  64. Role of TRPM2 in brain tumours and potential as a drug target
    Delphine Ji, Zhengwei Luo, Andrea Ovcjak, Rahmah Alanazi, Meihua Bao, Zhong‐Ping Feng, Hong‐Shuo Sun · 2021 · Acta Pharmacologica Sinica
  65. The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer’s Disease: An Overview and Update on New Developments
    Mohammad Rafi Khezri, Keyvan Yousefi, Ayda Esmaeili, Morteza Ghasemnejad‐Berenji · 2022 · Cellular and Molecular Neurobiology
  66. Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
    Anteneh Mehari Tizazu, H. M. Mengist, Gebreselassie Demeke · 2022 · Immunity & Ageing
  67. The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions
    Irina Kerkis, Álvaro Rossan de Brandão Prieto da Silva, Rodrigo Pinheiro Araldi · 2024 · Frontiers in Immunology
  68. Mechanistic Link between Vitamin B12 and Alzheimer’s Disease
    Anna Andrea Lauer, Heike S. Grimm, Birgit Apel, Nataliya Golobrodska, Lara Kruse, Elina Ratanski, Noemi Schulten, Laura Schwarze, Thomas Slawik, Saskia Sperlich et al. · 2022 · Publications of the UdS (Saarland University)
  69. Role of diet and exercise in aging, Alzheimer’s disease, and other chronic diseases
    Khemka, Sachi, Reddy, Aananya, Garcia, Ricardo Isaiah, Jacobs, Micheal, Reddy, Ruhananhad P., Roghani, Aryan Kia, Pattoor, Vasanthkumar, Basu, Tanisha, Sehar, Ujala, Reddy, P. Hemachandra · 2023 · Ageing Research Reviews
  70. Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients
    Ofer Nathan Gofrit, Benjamin Klein, Irun R. Cohen, Tamir Ben‐Hur, Charles L. Greenblatt, Hervé Bercovier · 2019 · PLoS ONE
  71. The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
    Julianna D. Zeidler, Kelly A. Hogan, Guillermo Agorrody, Thais Peclat, Sonu Kashyap, Karina S. Kanamori, Lilian Sales Gomez, Delaram Zamani Mazdeh, Gina M. Warner, Katie L. Thompson et al. · 2022 · American Journal of Physiology-Cell Physiology
  72. The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review
    Julie-Anne Therese Matheson, R. M. Damian Holsinger · 2023 · International Journal of Molecular Sciences
  73. Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
    Nathalie Moussa, Ninar Dayoub · 2023 · Saudi Pharmaceutical Journal
  74. The Gut Microbiota Modulates Neuroinflammation in Alzheimer's Disease: Elucidating Crucial Factors and Mechanistic Underpinnings
    Jianshe Yang, Junyi Liang, Niyuan Hu, Ningjuan He, Bin Liu, Guoliang Liu, Ying Qin · 2024 · CNS Neuroscience & Therapeutics
  75. Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
    Georgia R. Frost, Lauren A. Jonas, Yue‐Ming Li · 2019 · Frontiers in Aging Neuroscience
  76. Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia
    Eric E. Abrahamson, Miloš D. Ikonomović · 2020 · Experimental Neurology
  77. The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications
    Ahmed Sayed, Eshak I. Bahbah, Serageldin Kamel, George Emilio Barreto, Ghulam Md Ashraf, Mohamed Elfil · 2020 · Journal of Neuroimmunology
  78. The Role of Chronic Inflammation in Various Diseases and Anti‐inflammatory Therapies Containing Natural Products
    Renxiao Wang, Mi Zhou, Hui‐Lai Ma, Yuanbiao Qiao, Qingshan Li · 2021 · ChemMedChem
  79. The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions
    Rawan M. Tarawneh, Elena Penhos · 2022 · Neuroscience & Biobehavioral Reviews
  80. Camellia oil alleviates the progression of Alzheimer's disease in aluminum chloride-treated rats
    Ming-Hung Weng, Sheng-Yi Chen, Zih‐Ying Li, Gow‐Chin Yen · 2020 · Free Radical Biology and Medicine
  81. Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders
    Joanna K. Winstone, Khyatiben V. Pathak, Wendy Winslow, Ignazio Stefano Piras, Jennifer White, Ritin Sharma, Matthew J. Huentelman, Patrick Pirrotte, Ramón Velázquez · 2022 · Journal of Neuroinflammation
  82. Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases
    Tarun Pant, Nnamdi Uche, Matea Juric, Jacek Zielonka, Xiaowen Bai · 2024 · Redox Biology
  83. Alzheimer’s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model
    Carling, Gillian K., Fan, Li, Foxe, Nessa R., Norman, Kendra, Wong, Man Ying, Zhu, Daphne, Corona, Carlo, Razzoli, Agnese, Yu, Fangmin, Yarahmady, Allan et al. · 2024 · Neuron
  84. The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions
    Rameez Hassan Pirzada, Nasir Javaid, Sangdun Choi · 2020 · Genes
  85. Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
    Huihui Zeng, Yujie Qi, Zheyu Zhang, Chuntai Liu, Weijun Peng, Yi Zhang · 2021 · Chinese Chemical Letters
  86. Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot
    Liao, Wang, Xu, Jiaxin, Li, Bo, Ruan, Yuting, Li, Tian, Liu, Jun · 2022 · Frontiers in Pharmacology
  87. Reactive gliosis in traumatic brain injury: a comprehensive review
    Zuzana Amlerova, Martina Chmelová, Miroslava Anděrová, Lýdia Vargová · 2024 · Frontiers in Cellular Neuroscience
  88. PSYCHIATRY IN TIME OF COVID-19 PANDEMIC
    Carlo Giuseppe Lazzari, Ahmed Shoka, Abdul Nusair, Marco Rabottini · 2020 · Psychiatria Danubina
  89. Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
    Adrian Florian Bălașa, Cristina Chircov, Alexandru Mihai Grumezescu · 2020 · Biomedicines
  90. NM101 Phase III Study of NE3107 in Alzheimer’s Disease: rationale, Design and Therapeutic Modulation of Neuroinflammation and Insulin Resistance
    Reading, Christopher L, Ahlem, Clarence N, Murphy, Michael F · 2021 · Neurodegenerative Disease Management
  91. Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease
    Fahadul Islam, Jannatul Fardous Khadija, Md. Harun-Or-Rashid, Md. Saidur Rahaman, Mohamed H. Nafady, Md. Rezaul Islam, Aklima Akter, Talha Bin Emran, Polrat Wilairatana, Mohammad Suleiman Mubarak · 2022 · Oxidative Medicine and Cellular Longevity
  92. Helicobacter pylori infection in the stomach induces neuroinflammation: the potential roles of bacterial outer membrane vesicles in an animal model of Alzheimer’s disease
    Ah-Mee Park, Ikuo Tsunoda · 2022 · Inflammation and Regeneration
  93. Blood–brain barrier opening of the default mode network in Alzheimer’s disease with magnetic resonance-guided focused ultrasound
    Meng, Ying, Goubran, Maged, Rabin, Jennifer S, McSweeney, Melissa, Ottoy, Julie, Pople, Christopher B, Huang, Yuexi, Storace, Alexandra, Ozzoude, Miracle, Bethune, Allison et al. · 2023 · Brain
  94. Immune responses and immunosuppressive strategies for adeno-associated virus-based gene therapy for treatment of central nervous system disorders: current knowledge and approaches
    Prasad, Suyash, Dimmock, David P., Greenberg, Benjamin, Walia, Jagdeep S., Sadhu, Chanchal, Tavakkoli, Fatemeh, Lipshutz, Gerald S. · 2022 · Human Gene Therapy
  95. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients
    Steven Trent DeKosky, Patrick Michael Kochanek, Alex B. Valadka, Robert S. B. Clark, Sherry Chou, Alicia K. Au, Christopher M. Horvat, Ruchira Menka Jha, Rebekah Mannix, Stephen R. Wisniewski et al. · 2020 · Journal of Neurotrauma
  96. An NIR-Driven Upconversion/C3N4/CoP Photocatalyst for Efficient Hydrogen Production by Inhibiting Electron–Hole Pair Recombination for Alzheimer’s Disease Therapy
    Kezhen Ge, Zheng Li, Ali Wang, Zetai Bai, Xing Zhang, Xin Zheng, Zhao Liu, Fenglei Gao · 2023 · ACS Nano
  97. P-tau217 as a Reliable Blood-Based Marker of Alzheimer’s Disease
    Roy Lai, Brenden Li, Ram Jeevan Bishnoi · 2024 · Biomedicines
  98. IL-1β, IL-6, IL-10, and TNF α Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer’s Disease Pathology
    Mirjana Babić Leko, Matea Nikolac Perković, Nataša Klepac, Dubravka Švob Štrac, Fran Borovečki, Nela Pivac, Patrick R. Hof, Goran Šimić · 2020 · Journal of Alzheimer s Disease
  99. An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes
    Katrin Colleselli, Anna Stierschneider, Christoph Wiesner · 2023 · International Journal of Molecular Sciences
  100. The Links between Cardiovascular Diseases and Alzheimer's Disease
    Jerzy Leszek, Михайленко Елизавета Вячеславовна, Dmitrii M. Belousov, Effrosyni Koutsouraki, Katarzyna Szczechowiak, Małgorzata Kobusiak−Prokopowicz, Andrzej Mysiak, Breno Satler Diniz, Siva G. Somasundaram, Cecil E. Kirkland et al. · 2020 · Current Neuropharmacology